Dr. Jain is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
525 E 68th St
Fl 3
New York, NY 10065Phone+1 646-962-2072
Education & Training
Topiwala National Medical CollegeClass of 2007
Certifications & Licensure
FL State Medical License 2018 - 2026
NY State Medical License 2018 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- A Single Institution Experience in the Management of Localized Neuroendocrine Carcinoma of the Bladder.Casey Liveringhouse, Austin J Sim, Jingsong Zhang, Rohit K Jain, Shreyas U Naidu
Clinical Genitourinary Cancer. 2024-12-01 - TROPHY-U-01 Cohort 2: A Phase II Study of Sacituzumab Govitecan in Cisplatin-Ineligible Patients With Metastatic Urothelial Cancer Progressing After Previous Checkpoin...Daniel P Petrylak, Scott T Tagawa, Rohit K Jain, Manojkumar Bupathi, Arjun Balar
Journal of Clinical Oncology. 2024-10-10 - Impact of Angiotensin Converting Enzyme Inhibitors on Pathologic Complete Response With Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer.William Paul Skelton 4th, Jack Masur, Jonathan Thomas, Parvaneh Fallah, Rohit K Jain
Clinical Genitourinary Cancer. 2024-10-01
Press Mentions
Brooklyn ImmunoTherapeutics Announces Presentation of Ongoing Investigator Sponsored Trial of IRX-2 Regimen Combined with Nivolumab in Recurrent/Metastatic Solid TumorsJune 3rd, 2019
ProgramJanuary 13th, 2024- First-Line Combo for Cisplatin-Ineligible Bladder Cancer Just Misses Positive ResultJanuary 30th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
